1. Radiopharmaceutical Production
Cyclotron Facilities and FDG Radiopharmaceutical Production
Click here to proceed to the Introduction

2. Forward
The application of radionuclides in medicine has undergone significant growth in the last decade and one of the major factors contributing to this increased growth is the availability of a large number of cyclotrons exclusively dedicated to this purpose. Many of these cyclotrons are dedicated to the production of PET isotopes and more specifically, fluorine-18 for the production of 18F-FDG (fluorodeoxyglucose).
Grateful acknowledgement is given to the IAEA for sponsoring this project and to Brookhaven National Laboratory for support the electronic distribution of this material.
Comments and suggestions may be sent to either
David Schlyer or
Mohammad Haji-Saeid

3. Web Information Presentation
This series of presentations is intended to be a readily accessible platform with background material and practical information on operating a radiopharmaceutical production facility with an emphasis on the production of FDG.
The material was assembled by a group of people who are involved in PET radiopharmaceutical production. This tutorial describes processes and procedures that may be used in the preparation of PET radiopharmaceuticals. Other processes and procedures that are not described in this tutorial may also be acceptable
Click here or on the forward arrow to proceed with the
Explanation and Navigation
Click here to proceed directly to the Overview (not recommended for first time visitors)
Overview

4. Philosophical Organizational Structure
This series of presentations is intended to be a readily accessible platform with background material and practical information on operating an FDG production facility,
As an example: the operation of the cyclotron at different levels
Basics
Level 1
What is a cyclotron?
Few Details
Level 2
What are the major components of the cyclotron?
More Details
Level 3
How do the components work together and what is the basic theory?
Complete (Not in these presentations)
Level 4
What is the theory and all the parameters behind the operation of each component?

5. Introduction
This informational module is designed to give you an introduction to the production of radiopharmaceuticals. It is a self guided tour and you can learn about any specific topic by clicking on the pictures in the overview or by navigating to a specific presentation.
You can navigate within a presentation using the navigation buttons shown on the right side of this slide.
Click on the stop button to end the presentation you are viewing and return to the previous presentation. Hitting the stop button repeatedly will bring you back to this presentation.
Home button takes you to the table of contents slide
Go to the next slide
STOP
Go to the previous slide
Clicking on the blue arrows in each section will take you to a new presentation to learn more about a specific topic.
Go to the next section
More
The back section button takes you to the beginning of the section
Go on to the next slide

6. Radiopharmaceutical Production
Quality Control
Product Release
Dispensing - shipping
Cyclotron Operations
Cyclotron Targetry
Radionuclide Transfer
FDG Production
GMP
Quality Assurance
Click on a picture or box to learn more
Production Environment
Equipment Requirements
Radiation Protection
Validation
Send comments to
Personnel

7. Good Manufacturing Navigation Tree
US FDA
Regulations
Good Manufacturing
Practices
GMP
Regulations EU
Regulations
WHO Quality
Guidance
WHO
GMP Powerpoint
You may continue to the next slide to learn more about Good Manufacturing Practices or jump directly to a presentation by clicking on the name.
Intro to GMP
Pradeep Garg
Intro to GMP
Nicholas Buhay

8. Good Manufacturing Practices
The purpose Of GMP is to assure the identity, strength, quality, and purity of drug products. This is accomplished by requiring that manufacturers of pharmaceuticals adequately control manufacturing operations.  This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories.  This formal system of controls at a radiopharmaceutical production facility, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors.  This assures that drug products meet their quality standards.
GMP can be summarized as the necessary level of control over the operation and administration of facilities, methods and processes which will lead to the manufacture of radiopharmaceutical products of consistently high quality
(to assure that the products meet the requirements as to safety and effectiveness which the product purports).
More about GMP can be found here.
More
GMP
Regulations

9. Quality Assurance Navigation Tree
Site Master File
Quality Assurance
Quality
Management
Quality Manual
Job Responsibility
Operating Instructions
You may continue to the next slide to learn more about Good Manufacturing Practices or jump directly to a presentation by clicking on the name.
SOPs
Documentation

10. Quality Assurance Quality Assurance
Organization
and Personnel
Buildings
and Facilities
Equipment
Process
Validation
Records
and Reports
Quality Manual
Packaging and
Labeling Control
Storage and
Distribution
Quality Assurance
Quality Assurance is a systematic process focused on providing confidence that quality requirements will be fulfilled.
Quality Assurance (QA) encompasses all aspects of radiopharmaceutical production.
The development of a good quality assurance program requires a series of documents which can be confusing to the newcomer
To learn more about the development of a
Quality Assurance program, follow the arrow
More
Quality
Management

11. Personnel Navigation Tree
Personnel and
Quality Assurance
Personnel
Job Responsibilities
You may continue to the next slide to learn more about Personnel and Quality Assurance or jump directly to a presentation by clicking on the name.

12. Personnel
The facility for production of PET radioisotopes and radiopharmaceuticals/radiotracers will require a staff representing a wide range of job titles and training requirements. The staff should have the formal education, training and experience necessary to carry out the assigned tasks. The job functions include both production personnel and quality control personnel as well as some support functions
Quality Assurance is a way of thinking to ensure that the product being produced is effective and safe for human use. Quality Assurance includes the validation of equipment, the validation of the process, and the documentation.
Personnel
More
More
Job Responsibilities

13. Production Environment Navigation Tree
Environment EU
You may continue to the next slide to learn more about Facilities and Equipment or jump directly to a presentation by clicking on the name.
Production
Environment USA
Production
Environment
Radiation
Protection
Validation
Master Plan
Equipment
Requirements
Equipment
Validation
Validation
Quality
Management
Process
Validation

14. Production Environment
A radiopharmaceutical production facility includes several types of areas and the equipment that resides in those areas. There are:
Open or Uncontrolled areas – These are the normal laboratory and controlled areas that are used to manufacture the radiopharmaceutical and must comply with GMP regulations
Radiation Protection –Radiation protection is a concern in a production facility. There are regulations concerning the handling of radiation and instruments are required to measure the levels of radioactivity in a laboratory to ensure it is always contained
Production Equipment and Instruments – These include all the equipment to produce the radiopharmaceutical and the instruments used to analyze the final product. A List of Required Equipment can be found here.
More
Production
Environment USA
More
Production
Environment EU
Radiation
Protection
More
Equipment
Requirements
More
The equipment and process must be validated as described here
Validation

15. Validation
The first step in validation is to create a validation master plan (VMP). The VMP documents the way the facility will operate, who has control over the various aspects of the validation activities, and how production, quality control, and personnel management will be directed. To learn more about the VMP, follow the arrow.
All the equipment used in the manufacture of any radiopharmaceutical must be validated to be sure that it will give accurate and meaningful results for all the tests required before the product is released for human use. This includes being sure that the equipment is designed to perform the tests, that it is installed properly, that it is operating properly and that it is performing properly. This is part of the QA function. To learn more about Equipment Validation Specifics, follow the arrow
To learn about Quality Assurance and Quality Management, see
Some tests such as the sterility test cannot be completed before the product is delivered. Because of this, it is very important that the whole process be validated. Read more about process validation.
Validation
Master Plan
More
More
Equipment
Validation
Quality
Management
More
Process
Validation
More

16. Cyclotron and Targetry Navigation Tree
History
Cyclotron
Operations
Cyclotron
Basics
You may continue to the next slide to learn more about Cyclotrons and Targetry or jump directly to a presentation by clicking on the name.
Commercial
Cyclotrons
Cyclotron and
Targetry
Nuclear Reactions
Target Physics
Beam Heating
Density Reduction
Cyclotron
Targetry
Target
Foils
Radionuclide
Transfer
Practical
Target Design

17. Cyclotron and Targetry
The cyclotron is a particle accelerator which is used to produce the radionuclides. It accelerates a charged particle to very high energies. In most cases considered here, this charged particle will be a negatively charged hydrogen ion. Learn about cyclotrons here.
Once the charged particle reaches high enough energies, it is directed out of the cyclotron and hits a target material and makes the radionuclide. An example of this process is the reaction of oxygen-18 enriched water with protons to make fluorine-18. Learn more about cyclotron targetry.
Once the radionuclide is made, it may be extracted from the target material used in the irradiation. In the case of FDG, the F-18 can be extracted from the O-18 water using a resin column. It must then be transferred out of the cyclotron vault and into the chemistry laboratory. This may be a short distance through a wall or a rather long distance depending on the placement of the cyclotron in the facility. Learn more about radionuclide transfer.
More
Cyclotron
Operations
More
Cyclotron
Targetry
More
Radionuclide
Transfer

18. FDG Production Navigation Plan
You may continue to the next slide to learn more about FDG production or jump directly to a presentation by clicking on the name.
FDG Synthesis
Chemistry
FDG Production
FDG Synthesizers
How FDG
Synthesizers Work
Troubleshooting
Guide

19. FDG Production
In order to produce a radiopharmaceutical, it necessary to set up a laboratory to accommodate all the equipment and personnel, and to carry out production in a safe and clean environment. The laboratory usually will usually contain:
General laboratory equipment for usual chemical operations as described in the Facility and Equipment section
Analytical equipment to analyze the final product to ensure it is safe and meets all standards of purity and identity as described in the Facility and Equipment section
Production equipment to produce the radiopharmaceutical. This is usually a synthesis module and there are several for FDG by various manufacturers. More information about the synthesis of FDG, the operation of the synthesizers and the synthesizers available can be found by following the arrow
FDG Synthesizers
More

20. Quality Control Testing Product Release Navigation Tree
You may continue to the next slide to learn more about Quality Control Testing and Product Release or jump directly to a presentation by clicking on the name.
This tutorial describes processes and procedures that may be used in the preparation of PET radiopharmaceuticals. Other processes and procedures that are not described in this tutorial may also be acceptable
GMP
Regulations
Quality Control Testing
Product Release
Quality
Control
Product
Release
Shipping
IAEA Pub 1225

21. Quality Control Testing Product Release
Quality Control of the final product is one of the most critical steps in the production of the radiopharmaceutical. It is where the final determination is made as to whether or not the radiopharmaceutical can be used in a patient. There are extensive regulations from different governing bodies which govern these tests and regulate production. The regulations can be found here.
The testing that is done for PET radiopharmaceuticals has to be done quickly since the half-life of the radiopharmaceutical is so short. There are a series of very specific tests which must be carried out. These include tests of both chemical and radiochemcial purity, conformation of radiochemical identity, pH, sterility and to ensure the dose does not contain dangerous levels of pryogens. More information about these tests and a discussion of the methods can be found by following the arrow.
Before a product can be released for clinical use, it must approved. This can only be done by an authorized person (qualified person). To learn more about the qualifications necessary and the formal documents that are used to document the release, follow the arrow.
GMP
Regulations
More
More
Quality
Control
Product
Release
More

22. Return to the main menu